Price target
49.330.00 0.00%
The 12 analysts offering 1 year price forecasts for BBIO have a max estimate of — and a min estimate of —.
Analyst rating
Based on 13 analysts giving stock ratings to BBIO in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BBIO EPS for the last quarter is −0.20 USD despite the estimation of −0.74 USD. In the next quarter EPS is expected to reach −0.97 USD. Track more of BridgeBio Pharma, Inc. financials and stay on top of what is up with the company.
In the next quarter BridgeBio Pharma, Inc. revenue is expected to reach 4.72 M USD. Check out BridgeBio Pharma, Inc. revenue and earnings and make informed decisions.
According to analysts, BBIO price target is 49.33 USD with a max estimate of 70.00 USD and a min estimate of 33.00 USD. Check if this forecast comes true in a year, meanwhile watch BridgeBio Pharma, Inc. stock price chart and keep track of the current situation with BBIO news and stock market news.
We've gathered opinions of 13 analysts rating BBIO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.